MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to bausch + lomb...
-$360M
Vision Care
$2,923M
Pharmaceuticals
$1,284M
Surgical
$894M
Net loss
-$352M
Net income
attributable to...
$8M
Total revenues
$5,101M
Loss before
provision for income taxes
-$317M
Provision for income taxes
$35M
Operating income
$113M
Expected provision for
income taxes at...
-$79M
Interest income
$12M
Total expenses
$4,988M
Intercompany profit in ending
inventory-IE
-$18M
Foreign tax rate
differences-DE
-$8M
Research & development
tax credits-US
$8M
Capital loss on sale of
assets-IE
-$7M
Contingent consideration
fair value...
-$6M
Foreign tax rate
differences-US
-$5M
Interest expense
$421M
Foreign tax rate
differences-IE
$49M
Foreign exchange and
other
-$15M
Foreign exchange
impact-CA
$24M
Disallowed interest-IE
$17M
Change in valuation
allowance-CA
$15M
Non-deductible amount of
share-based compensation
$14M
Loss on
extinguishment of debt
-$6M
Selling, general and
administrative (note 3)
$2,234M
Cost of goods sold
(excluding amortization...
$2,045M
Research and development
$371M
Amortization of intangible
assets
$258M
Other expense, net
-$75M
Cost of goods sold
(excluding amortization...
$5M
Change in valuation
allowance-IE
$11M
Foreign tax rate
differences-Foreign Tax...
$7M
Disallowed interest-CA
$5M
Foreign exchange
impact-IE
$5M
Change in valuation
allowance-NL
$4M
Other-US
$4M
Effects of cross-border
taxes-US
$4M
Effects of cross-border
taxes-CA
$2M
Other-DE
$2M
Intercompany profit in ending
inventory-US
$2M
Other-NL
$1M
Back
Back
Income Statement
source: myfinsight.com
Bausch & Lomb Corp (BLCO)
Bausch & Lomb Corp (BLCO)